Sectors
HCAT
Health Catalyst, Inc.
1.85
3 x 1.76
1 x 2.20
bid
ask
+
0.10
5.71%
undefined @ 04:00 PM
1.85 +0.00 (0.00%)
| Ytd | -22.59% | |
| 1y | -36.64% |
1.76
day range
1.89
1.00
52 week range
3.69
| Open | 1.77 | Prev Close | 1.75 | Low | 1.76 | High | 1.89 | Mkt Cap | 136.70M |
| Vol | 917.69K | Avg Vol | 1.65M | EPS | 0.20 | P/E | 9.25 | Forward P/E | 16.52 |
| Beta | 1.32 | Short Ratio | 5.03 | Inst. Own | 90.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.99 | 200-d Avg | 1.96 | 1yr Est | 11.41 |
| Income Statement | |||
| Total Revenue | 70.49M | ||
| Revenues (USD) | 70.49M | ||
| Cost of Revenue | 35.63M | ||
| Gross Profit | 34.86M | ||
| Operating Expenses | 71.34M | ||
| Research and Development Expense | 11.03M | ||
| Selling, General and Administrative Expense | 22.29M | ||
| Operating Income | -36.48M | ||
| Interest Expense | 3.74M | ||
| Income Tax Expense | 315.00K | ||
| Net Income | -40.54M | ||
| Net Income Common Stock | -40.54M | ||
| Net Income Common Stock (USD) | -40.54M | ||
| Consolidated Income | -40.54M | ||
| Earnings per Basic Share | -0.55 | ||
| Earnings per Basic Share (USD) | -0.55 | ||
| Earnings per Diluted Share | -0.55 | ||
| Earning Before Interest & Taxes (EBIT) | -36.48M | ||
| Earning Before Interest & Taxes (USD) | -36.48M | ||
| Weighted Average Shares | 73.96M | ||
| Weighted Average Shares Diluted | 73.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 60.59M | ||
| Cash and Equivalents (USD) | 60.59M | ||
| Investments | 42.85M | ||
| Investments Current | 42.85M | ||
| Trade and Non-Trade Receivables | 41.90M | ||
| Current Assets | 248.39M | ||
| Property, Plant & Equipment Net | 39.41M | ||
| Total Assets | 358.60M | ||
| Debt Current | 5.33M | ||
| Total Debt | 169.98M | ||
| Current Liabilities | 91.93M | ||
| Debt Non-Current | 164.65M | ||
| Total Liabilities | 257.78M | ||
| Accumulated Retained Earnings (Deficit) | -1.52B | ||
| Accumulated Other Comprehensive Income | 1.03M | ||
| Shareholders Equity | 100.83M | ||
| Shareholders Equity (USD) | 100.83M | ||
| Assets Non-Current | 110.21M | ||
| Total Debt (USD) | 169.98M | ||
| Deferred Revenue | 42.96M | ||
| Goodwill and Intangible Assets | 67.22M | ||
| Liabilities Non-Current | 165.85M | ||
| Trade and Non-Trade Payables | 8.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.53M | ||
| Net Cash Flow from Financing | -450.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 725.00K | ||
| Capital Expenditure | -5.14M | ||
| Issuance (Purchase) of Equity Shares | -43.00K | ||
| Issuance (Repayment) of Debt Securities | -407.00K | ||
| Net Cash Flow from Investing | 902.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.35M | ||
| Net Cash Flow from Operations | 275.00K | ||
| Effect of Exchange Rate Changes on Cash | -2.00K | ||
| Share Based Compensation | 2.71M | ||